Sidley Austin advised Armis on the transaction, and Wilson Sonsini Goodrich & Rosati advised Silk Security. Armis, the asset intelligence cybersecurity company, announced that it has...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Sagard Healthcare in the transaction, and Cooley represented MannKind Corporation. Sagard Healthcare (Sagard) announced it entered into a royalty purchase agreement, under which...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Praxis Precision Medicines, Inc. in the transaction, and Ropes & Gray advised Tenacia. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) announced it has entered...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP represented Novo Nordisk Inc. in the matter. Novo Nordisk (NYSE: NVO) announced its collaboration with Evotec SE (NASDAQ: EVO) to launch LAB eN² (pronounced Lab...
You must be a Standard 1 Year member to access this content.
Sidley represented Placer.ai on the deal. Placer.ai, a geolocation and proximity data analytics technology startup, announced its US$100 million Series C financing, which was led by Josh...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
You must be a Standard 1 Year member to access this content.
